Antiva Biosciences, Inc.

New Filing
CIK: 0001563355·Biotechnology·DELAWARE·Filed: Jul 19, 2018
Total Offering

$15,000,000

Amount Sold

$15,000,000

Investors

8

First Sale

Jul 6, 2018

Offering Details

Type
Equity, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Gail Maderis
Related Person
Michael D. Cannon
Related Person
Oranee Daniels
Related Person
Raju Gadiraju, Ph.D.
Related Person
Wende S. Hutton
Related Person
Steven P. James
Related Person
Ting Jia
Related Person
David Kabakoff, Ph.D.
Related Person
Vinzenz Ploerer
Related Person
Benjamin Rovinski
Related Person
Sarah Walter
Related Person

Company

Antiva Biosciences, Inc.

6000 SHORELINE COURT

SOUTH SAN FRANCISCO, CA, 94080

(650) 822-1400

SEC Filing

0001563355-18-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free